Investigating blood eosinophil count thresholds in patients with COPD

Investigating blood eosinophil count thresholds in patients with COPD

Bibliographic Details
Main Authors:	Russell, R, Bafadhel, M
Format:	Journal article
Language:	English
Published:	Elsevier 2018

Similar Items

Blood eosinophil count and exacerbation risk in patients with COPD.
by: Kerkhof, M, et al.
Published: (2017)

Association between blood eosinophil count and risk of exacerbations in patients with COPD
by: Kerkhof, M, et al.
Published: (2017)

Blood eosinophil count and GOLD stage predict response to maintenance azithromycin treatment in COPD patients with frequent exacerbations
by: Djamin, R, et al.
Published: (2019)

Characterising non-eosinophilic COPD
by: Hambleton, K, et al.
Published: (2015)

Eosinophils in COPD: just another biomarker?
by: Bafadhel, M, et al.
Published: (2017)

The peripheral blood eosinophil count as a biomarker of eosinophilic airway inflammation in patients with asthma and COPD. Experience from a single centre
by: Shrimanker, R, et al.
Published: (2017)

Case series of long-term macrolide therapy effect on eosinophil count in COPD
by: Asciak, R, et al.
Published: (2017)

Comparison of the peripheral blood eosinophil count using near-patient testing and standard automated laboratory measurement in healthy, asthmatic and COPD subjects
by: Hambleton, K, et al.
Published: (2017)

Blood eosinophil count and airway epithelial transcriptome relationships in COPD versus asthma
by: George, L, et al.
Published: (2019)

Late Breaking Abstract - Protection by budesonide against clinically important deteriorations (CID) in patients with COPD is dependent on blood eosinophil counts (EOS)
by: Bafadhel, M, et al.
Published: (2018)

Blood Eosinophils and outcomes in severe hospitalized exacerbations of COPD
by: Bafadhel, M, et al.
Published: (2016)

Investigating the role of the eosinophil in COPD
by: Camp, JR
Published: (2023)

Seasonality of eosinophilic and non-eosinophilic exacerbations of COPD
by: Barker, R, et al.
Published: (2017)

Peripheral blood eosinophil drop-to-drop variation in patients with COPD using near patient testing: a small validation study
by: Jeffers, H, et al.
Published: (2017)

Blood eosinophil levels as a biomarker in COPD
by: Brusselle, G, et al.
Published: (2018)

Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis.
by: Bafadhel, M, et al.
Published: (2014)

Mepolizumab for eosinophilic COPD
by: Sciurba, F, et al.
Published: (2018)

Eosinophil migration is enhanced towards IL-5 and eotaxin in COPD
by: Lababidi, R, et al.
Published: (2017)

Copd in the ed: eosinophils, treatment and outcomes, data from the pre-award study
by: Russell, R, et al.
Published: (2016)

Can NPT be used to distinguish eosinophilic inflammatory phenotypes in COPD?
by: Hambleton, K, et al.
Published: (2016)

Modelling peripheral blood eosinophils to identify response to budesonide in COPD: a post-hoc analysis
by: Bafadhel, M, et al.
Published: (2017)

The significance of eosinophilic inflammation in COPD
by: Cooper, C, et al.
Published: (2017)

Association between blood eosinophil counts and risk of rehospitalization in patients with asthma
by: Kerkhof, M, et al.
Published: (2017)

Predicting inhaled steroid responsiveness using blood eosinophil counts: personalising long-term management of COPD in primary care
by: Ashdown, HF
Published: (2019)

The association between blood eosinophils and risk and treatment outcome in COPD is not dichotomised
by: Pascoe, S, et al.
Published: (2018)

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
by: Siddiqui, S, et al.
Published: (2018)

COPD exacerbation severity and frequency is associated with impaired macrophage efferocytosis of eosinophils
by: Eltboli, O, et al.
Published: (2014)

Changes in the peripheral blood eosinophil count in falciparum malaria.
by: Davis, T, et al.
Published: (1991)

Fractional exhaled nitric oxide and the peripheral blood eosinophil count as biomarkers of the response to mepolizumab in patients with severe eosinophilic asthma
by: Shrimanker, R, et al.
Published: (2018)

Shall we focus on the eosinophil to guide treatment with systemic corticosteroids during acute exacerbations of COPD?: PRO
by: Camp, J, et al.
Published: (2018)

Association between blood eosinophil count and risk of readmission for patients with asthma: Historical cohort study
by: Kerkhof, M, et al.
Published: (2018)

Are COPD and cardiovascular disease fundamentally intertwined?
by: Bafadhel, M, et al.
Published: (2016)

Automatic generation of personalised alert thresholds for patients with COPD
by: Velardo, C, et al.
Published: (2014)

What will happen in the world of COPD 2030?
by: Russell, REK, et al.
Published: (2019)

Biomarkers in COPD
by: Ramakrishnan, S, et al.
Published: (2021)

Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial.
by: Siva, R, et al.
Published: (2007)

Asthma exacerbations and sputum eosinophil counts.
by: Currie, G, et al.
Published: (2003)

Use of blood eosinophils to predict outcomes under inhaled maintenance treatment in steroid-naïve COPD patients in primary care: new user cohort study using the clinical practice research datalink
by: Ashdown, H, et al.
Published: (2018)

Blood eosinophil count and pneumonia risk in patients with chronic obstructive pulmonary disease: a patient-level meta-analysis
by: Pavord, I, et al.
Published: (2016)

Late breaking abstract - Dose-ranging study of mepolizumab in eosinophilic COPD
by: Pavord, I, et al.
Published: (2017)